72094EGP
- Active ingredient
- ipilimumab
- Strength
- 50mg/10 ml
- Form
- vial
- Manufacturer
- bristol-myers squibb > middle east
- Route
- injection
Uses
Used for the treatment of certain advanced cancers including melanoma and other selected malignancies.
Do not use if
Hypersensitivity to ipilimumab or formulation components.
Side effects
Immune-mediated adverse reactions, diarrhea, rash, and fatigue may occur.
Warnings
Monitor closely for severe immune-mediated toxicities.
How it works
Monoclonal antibody that blocks CTLA-4 and enhances antitumor immune responses.
Storage
Store refrigerated at 2–8°C.